By Andrew Livingston, Shawn Hauser, Dwight Clark, Mason Tvert
Dec 18, 2020
This VS white paper explains why the current medical marijuana program is falling short and how policymakers can improve patient access, treatment outcomes, and the health of the program. It also explores how such changes would impact the medical cannabis market.
By Christina Sava
Dec 11, 2020
A brief history of cannabis regulation in The Golden State over the last decade.
By Kelsey Middleton
Dec 2, 2020
A recent ruling determined that the Bureau of Cannabis Control exceeded its rulemaking authority by allowing any advertising to be seen on interstate highways and state highways crossing the California border.
By Shawn Hauser
Dec 1, 2020
This week marks a historic milestone in cannabis policy as both the United Nations and the U.S. House of Representatives consider modernizing prohibitionist cannabis laws.
By Vicente Sederberg LLP
Dec 1, 2020
For our 10th anniversary, we take a look back at VS's history of leadership in cannabis law, the marijuana and hemp industries, and drug policy reform.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.